The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000419.5(ITGA2B):c.998+1G>C

CA399804688

812734 (ClinVar)

Gene: ITGA2B (HGNC:3674)
Condition: Glanzmann thrombasthenia (MONDO:0100326)
Inheritance Mode: Autosomal recessive inheritance
UUID: aff8f164-2aa9-4376-b011-420535e3a386
Approved on: 2021-09-15
Published on: 2022-06-12

HGVS expressions

NM_000419.5:c.998+1G>C
NM_000419.5(ITGA2B):c.998+1G>C
NC_000017.11:g.44383893C>G
CM000679.2:g.44383893C>G
NC_000017.10:g.42461261C>G
CM000679.1:g.42461261C>G
NC_000017.9:g.39816787C>G
NG_008331.1:g.10613G>C
ENST00000262407.6:c.998+1G>C
ENST00000648408.1:n.429+1G>C
ENST00000262407.5:c.998+1G>C
ENST00000589645.5:n.450G>C
ENST00000591990.5:n.543+1G>C
ENST00000592226.5:n.238+1G>C
NM_000419.3:c.998+1G>C
NM_000419.4:c.998+1G>C
More

Pathogenic

Met criteria codes 3
PM3_Supporting PVS1 PM2_Supporting
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
NM_000419.5(ITGA2B):c.998+1G>C occurs within the canonical splice donor site of intron 11. It is predicted to cause skipping of biologically-relevant-exon 11/30, resulting in the p.(Met316Glufs*3) frameshift in exon 12, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). One homozygous patient has been reported with Glanzmann thrombasthenia (PMID: 32581362; PM3_supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1, PM2_supporting, PM3_supporting. (VCEP specifications version 2; date of approval xx/xx/xxxx)
Met criteria codes
PM3_Supporting
One homozygous patient has been reported with Glanzmann thrombasthenia (PMID: 32581362; PM3_supporting).
PVS1
NM_000419.5(ITGA2B):c.998+1G>C in occurs within the canonical splice donor site of intron 11. It is predicted to cause skipping of biologically-relevant-exon 11/30, resulting in the p.(Met316Glufs*3) frameshift in exon 12, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Not Met criteria codes
PP4
One patient has been reported with Glanzmann thrombasthenia in PMID: 32581362, however phenotypic information was not provided.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.